Poster Abstracts Submission: Closed   |   Final Registration Closes: Closed

Welcome Message

We welcome you to the 4th Neurological Disorders Summit on July 23-25, 2018 in Los Angeles, USA.

The summit will provide a unique opportunity to neuroscientists and physicians to share their research and experiences with the leaders in their fields. The program includes keynote speeches from internationally renowned scientists. Each of these speakers helped to shape the modern concepts of neuroscience. In addition, there will be sessions for oral and poster presentations. Presentations in these sessions will provide an overview of the cutting-edge technologies being used to address difficult therapeutic and theoretical issues in neuroscience.

NDS-2018 is unique in its approach of encouraging a dialogue between the basic and clinical scientists. We expect to have these dialogues both during scientific sessions and networking time. We hope to make the summit particularly educational and inspiring for young scientists who will get an opportunity to interact with leading experts.

The host city Los Angeles is home to top medical research centers and laboratories.

It also offers many award-winning ethnic and continental food choices. We take immense pride to welcome you to this exciting summit and hope you will have satisfying academic and social interaction in Los Angeles.

Rajendra Badgaiyan, MD(Chairman)
Kenneth Blum, PhD(Co-Chairman)

Scientific Sessions

  • Neurological disorders: Symptomatology, pathophysiology and etiology
  • Diagnostics of neurological disorders: Neuroimaging, biomarkers and laboratory studies
  • Alzheimer's disease, dementia and mild cognitive impairment
  • Parkinson's disease and other movement disorders
  • Neuromuscular disorders and peripheral neuropathies
  • Neurodegenerative diseases
  • Neuropathological disorders
  • CNS Neoplasia
  • Neurotransmitters, neuropeptides and drug targets‏
  • Neurobehavioral disorders
  • Prevention, treatment and therapeutic options
  • Autism and neurodevelopmental disorders
  • Epilepsy and seizure
  • Advances in stroke management
  • Stroke: Prevention, treatment and recovery
  • Multiple sclerosis and CNS demyelinating disorders
  • Migraine and headaches
  • Neuroengineering & rehabilitation
  • Case studies and ethical issues



$ 499


Access to main conference sessions, exhibits, poster sessions and round table discussions Conference material

Tea / Coffee breaks, lunch during the conference days

$ 949


Access to main conference sessions, exhibits, poster sessions and round table discussions Conference material

Tea / Coffee breaks, lunch during the conference days

Conference History

3rd Neurological Disorders Summit ( NDS-2017) organized by United Scientific Group concluded successfully on July 08, 2017 at Crowne Plaza Hotel, San Francisco, USA.

We thank all the participants of NDS-2017 for trusting us and contributing to a global platform where important aspects of various neurological disorders were discussed. The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who have driven this event into the path of success.

The summit inaugurated on July 06, 2017 in the golden gate city, San Francisco, USA by the Organizing Committee chairmen; Dr. Rajendra Badgaiyan and Dr. Kenneth Blum. The three day summit was divided into different sessions of keynote, oral and poster presentations which brought together an interdisciplinary group of professionals working on neurological disorders.

Dr. Kenneth Blum (Co-Chairman of NDS-2017), Wright State University, USA delivered the first keynote lecture of NDS-2017 on “Customized DNA (Precision Medicine) Directed Nutrition to Balance the Brain Reward Circuitry and Reduce Addictive Behaviors”. Dr. Blum discussed about different products that reduce cravings and addiction by influencing gene expression. It was then followed by keynote lecture of Dr. Howard J Federoff on “Plasma Metabolomic Profiles and Cognitive Function” in which he spoke about the implications of plasma metabolomic signature with regard to cognitive function and potential implications for dementia.

Read More


Panel discussions

Interactive poster session



Mentoring from senior faculty

Networking during customized social hours

Emerging Researcher Forum

Poster Competition

Raise an Agenda

NDS-2017 By Profession

Figure 1: NDS-2017 Attendees by Profession

NDS-2017 Country Wise Participation

Figure 2: NDS-2017 Country Wise Participation

Event Location